assembly_id	genome_id	genome_def	crispr_array_locus_merge	crispr_array_location_merge	crispr_locus_id	crispr_pred_method	array_in_prot	prot_within_array_20000	prot_in_genome	crispr_type_by_cas_prot	consensus_repeat	repeat_length	self-targeting_spacer_number	self-targeting_target_number	spacer_location	protospacer_location	repeat_type	spacer_locus_num	spacer_num	correct_crispr_type	genome_cas_prots	unknown_protein_around_crispr	L10	L10_domain	L9	L9_domain	L8	L8_domain	L7	L7_domain	L6	L6_domain	L5	L5_domain	L4	L4_domain	L3	L3_domain	L2	L2_domain	L1	L1_domain	R1	R1_domain	R2	R2_domain	R3	R3_domain	R4	R4_domain	R5	R5_domain	R6	R6_domain	R7	R7_domain	R8	R8_domain	R9	R9_domain	R10	R10_domain
GCF_007197715.1_ASM719771v1	NZ_CP041626	Dolosigranulum pigrum strain 83VPs-KB5 chromosome, complete genome	1	802439-803201	1,1,1	PILER-CR,CRISPRCasFinder,CRT	no	cas9,cas1,cas2,csn2	RT,cas3,cas9,cas1,cas2,csn2,DinG,DEDDh,csa3	Type II-B,Type II-A,Type II-C	GTTTTAGAGCTGTGTTGTTTTGAATGACTCCAAAAC,GTTTTAGAGCTGTGTTGTTTTGAATGACTCCAAAAC,GTTTTAGAGCTGTGTTGTTTTGAATGACTCCAAAAC	36,36,36	2	4	802937-802966|802937-802966|802937-802966|803003-803032	NZ_CP041626.1_1959043-1959014|NZ_CP041626.1_2011761-2011732|NZ_CP041626.1_2064479-2064450|NZ_CP041626.1_336465-336494	II-A,II-B:II-A,II-B:II-A,II-B	11,11,11	11	TypeII-B,TypeII-A,TypeII-C	RT,cas3,cas9,cas1,cas2,csn2,DinG,DEDDh,csa3	NA,NA	NA|386aa|up_9|NZ_CP041626.1_789087_790245_-	PRK06233, PRK06233, vitamin B12 independent methionine synthase	NA|247aa|up_8|NZ_CP041626.1_790288_791029_-	COG1878, COG1878, Kynurenine formamidase [Amino acid transport and metabolism]	NA|228aa|up_7|NZ_CP041626.1_791491_792175_+	COG0745, OmpR, Response regulators consisting of a CheY-like receiver domain and a winged-helix DNA-binding domain [Signal transduction mechanisms / Transcription]	NA|348aa|up_6|NZ_CP041626.1_792149_793193_+	cd16948, HATPase_BceS-YxdK-YvcQ-like, Histidine kinase-like ATPase domain of two-component sensor histidine kinases similar to Bacillus subtilis BceS, YxdK, and Bacillus thuringiensis YvcQ	NA|247aa|up_5|NZ_CP041626.1_793279_794020_+	COG1136, SalX, ABC-type antimicrobial peptide transport system, ATPase component [Defense mechanisms]	NA|632aa|up_4|NZ_CP041626.1_794021_795917_+	pfam02687, FtsX, FtsX-like permease family	cas9|1333aa|up_3|NZ_CP041626.1_796441_800440_+	COG3513, COG3513, Predicted CRISPR-associated nuclease, contains McrA/HNH-nuclease and RuvC-like nuclease domain [Defense mechanisms]	cas1|290aa|up_2|NZ_CP041626.1_800439_801309_+	cd09720, Cas1_II, CRISPR/Cas system-associated protein Cas1	cas2|116aa|up_1|NZ_CP041626.1_801305_801653_+	COG3512, COG3512, CRISPR-associated protein, Cas2 homolog [Defense mechanisms]	csn2|226aa|up_0|NZ_CP041626.1_801633_802311_+	cd09758, Csn2, CRISPR/Cas system-associated protein Csn2	NA|318aa|down_0|NZ_CP041626.1_803418_804372_+	cd12155, PGDH_1, Phosphoglycerate Dehydrogenase, 2-hydroxyacid dehydrogenase family	NA|600aa|down_1|NZ_CP041626.1_804387_806187_+	cd09609, M3B_PepF, Peptidase family M3B, oligopeptidase F (PepF)	NA|158aa|down_2|NZ_CP041626.1_806325_806799_-	cd00340, GSH_Peroxidase, Glutathione (GSH) peroxidase family; tetrameric selenoenzymes that catalyze the reduction of a variety of hydroperoxides including lipid peroxidases, using GSH as a specific electron donor substrate	NA|321aa|down_3|NZ_CP041626.1_806981_807944_+	PRK10783, mltD, membrane-bound lytic murein transglycosylase D; Provisional	NA|943aa|down_4|NZ_CP041626.1_808126_810955_+	PRK00349, uvrA, excinuclease ABC subunit UvrA	NA|556aa|down_5|NZ_CP041626.1_811105_812773_+	pfam13349, DUF4097, Putative adhesin	NA|100aa|down_6|NZ_CP041626.1_812756_813056_+	pfam04024, PspC, PspC domain	NA|61aa|down_7|NZ_CP041626.1_813167_813350_+	COG1983, PspC, Putative stress-responsive transcriptional regulator [Transcription / Signal transduction mechanisms]	NA|101aa|down_8|NZ_CP041626.1_813370_813673_+	pfam04024, PspC, PspC domain	NA|118aa|down_9|NZ_CP041626.1_813777_814131_+	pfam04020, Phage_holin_4_2, Mycobacterial 4 TMS phage holin, superfamily IV
